Table 3.

Type of hematological malignancy, time from GPA diagnosis, and survival time.

TypeTotal, n = 21Median Time from GPA Diagnosis, Yrs (range min–max)Median Survival Time, Mos (range min–max)
All cases218 (5–21)7.5 (0.25–117)*
  MDS316 (6–21)12 (2–12)
  MDS developing to AML96 (5–14)7.5 (2–23)
  AML78 (5–19)4 (0.25–12)
  CML213 (11–15)62.5 (8–117)*
  • * At end of followup December 31, 2012. GPA: granulomatosis with polyangiitis; MDS: myelodysplastic syndrome; AML: acute myeloid leukemia; CML: chronic myeloid leukemia.